USA FINANCIAL FORMULAS quarter change: Foreign ADRs, Sold out
In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), from the quarter ended 2025-12-31 to 2026-03-31, USA FINANCIAL FORMULAS opened 0 positions, added to 0, reduced 0, sold out of 1 and left 0 unchanged. The largest increase in value was Astrazeneca plc - ADR (-$925,092); the largest decrease was Astrazeneca plc - ADR (-$925,092).
- Astrazeneca plc - ADR: Country of operation —; Class SPONSORED ADR; Shares 2025-12-31 10,063; Shares 2026-03-31 0.
Two Form 13F-HR filings compared (SEC CIK 1633716): 2025-12-31 (filed 2026-01-14) and 2026-03-31 (filed 2026-04-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Balefire, LLC | United States | $0.531B | 439 |
| Baker Chad R | United States | $0.530B | 56 |
| ELEMENT POINTE ADVISORS, LLC | United States | $0.530B | 86 |
| Pettinga Financial Advisors LLC | United States | $0.531B | 163 |
| SOA Wealth Advisors, LLC. | United States | $0.530B | 867 |
| Taproot Management LP | United States | $0.530B | 180 |
| Strong Tower Advisory Services | United States | $0.531B | 92 |
| Kapitalo Investimentos Ltda | Brazil | $0.531B | 57 |
| Overbrook Management Corp | United States | $0.529B | 51 |
| Factor Wealth Management LTD | United States | $0.532B | 162 |